LifePoint, Inc. Invites You to Join its Second Quarter Fiscal 2004 Conference Call


ONTARIO, Calif., Nov. 3, 2003 (PRIMEZONE) -- LifePoint, Inc. (AMEX:LFP), announced that in conjunction with the Company's fiscal 2004 second quarter earnings release, you are invited to listen to its conference call on Thursday, November 13, 2003 at 4:30 p.m., EST (1:30 p.m. PST), with Linda H. Masterson, President and CEO and Don Rutherford, Vice President and CFO. The financial results for the second quarter, FY 2004 ended September 30, 2003 will be reported on November 13, 2003.


 What:  LifePoint, Inc.'s Fiscal 2004 Second Quarter Conference Call 

 When:  Thursday, November 13, 2003 at 4:30 p.m., EST

 Web address: www.streetevents.com, www.companyboardroom.com, or 
 www.LifePointInc.com 

 Dial-in numbers: 1-800-299-7635 and 1-617-786-2901  (international) 
 Passcode #36893261

If you are unable to participate, an audio digital replay of the call will be available from Thursday, November 13th at 6 p.m. EST until 6 p.m. EST, November 27th by dialing 1-888-268-8010 (domestic) or 617-801-6888 (international) using confirmation code #61302884. A web archive will be available for 30 days at www.streetevents.com, www.companyboardroom.com , or www.LifePointInc.com. The company will issue its quarterly letter to shareholders following the conference call.

About LifePoint, Inc.

LifePoint, Inc., a leader in non-invasive drug diagnostic technologies and solutions, has developed, manufactures and markets the IMPACT Test System - a rapid diagnostic testing, screening and drug monitoring device for use in the workplace, home health care, ambulances, pharmacies and law enforcement. LifePoint's patented and proprietary technologies for the use of saliva as a non-invasive, blood-comparable test specimen, used in conjunction with the flow immunosensor technology licensed from the United States Navy, has allowed LifePoint to develop a broadly applicable, rapid, on-site diagnostic test system. The first product simultaneously detects drugs of abuse and alcohol, with the initial three target markets estimated to be over $1.6 billion.

LifePoint(r) and IMPACT(r) are trademarks of LifePoint, Inc.

-O-
CONTACT:  LifePoint, Inc. 
          Linda H. Masterson, CEO & President
          (909) 418-3000, Ext. 400
          LifePoint@LFPT.com
          www.LifePointInc.com.

          Cameron Associates
          Lester Rosenkrantz
          (212) 245-8800, Ext. 212
          lester@cameronassoc.com